Logo

Similar Products

Description

Our Tamoxifen Citrate Tablets IP 20mg represent pharmaceutical excellence in selective estrogen receptor modulator therapy, manufactured using premium raw materials and advanced pr...
Our Tamoxifen Citrate Tablets IP 20mg represent pharmaceutical excellence in selective estrogen receptor modulator therapy, manufactured using premium raw materials and advanced production techniques to ensure consistent bioavailability and therapeutic efficacy. Each batch undergoes rigorous quality testing to verify chemical composition, dissolution rates, and stability parameters, complying with Indian Pharmacopoeia standards and packaged to maintain integrity throughout the supply chain. This unwavering commitment to quality makes our tablets a trusted choice for healthcare providers requiring reliable cancer treatment medications that deliver predictable clinical outcomes.

These tablets are extensively utilized in oncology departments, cancer treatment centers, and hospital pharmacies worldwide, serving as frontline therapy for hormone receptor-positive breast cancer cases across both private and public healthcare systems. Medical institutions value their consistent performance in adjuvant treatment protocols and preventive care programs, while specialized endocrine clinics and research institutions conducting women's health studies rely on their therapeutic reliability. Distribution networks include pharmaceutical wholesalers supplying clinics, hospitals, and retail pharmacies in domestic and international markets seeking proven cancer treatment solutions.

Business partners benefit from our commitment to product reliability and supply chain consistency, with volume-based pricing and flexible delivery schedules that meet diverse market needs. Our manufacturing processes incorporate multiple quality checkpoints ensuring every tablet meets specified potency and purity standards, while the product's shelf stability and batch-to-batch consistency reduce business risks for distributors and healthcare providers. We maintain comprehensive documentation and regulatory compliance support to facilitate smooth market entry and build lasting customer confidence in therapeutic outcomes.

Key Features:
- Precisely formulated 20mg dosage strength per tablet
- Manufactured using high-purity active pharmaceutical ingredients
- Complies with Indian Pharmacopoeia quality standards
- Produced in GMP-certified manufacturing facilities
- Rigorous quality testing for consistent therapeutic performance

Benefits:
- Reliable therapeutic outcomes for hormone-positive breast cancer treatment
- Consistent batch-to-batch quality and dosage accuracy
- Reduced business risk through stable shelf life and product consistency
- Compliance with international pharmaceutical standards
- Trusted performance in clinical and hospital settings

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Tamoxifen Citrate Tablets IP 20mg provide essential therapeutic action in oncology and endocrine treatment protocols. These tablets are specifically designed for managing hormone receptor-positive breast cancer in both premenopausal and postmenopausal women, offering reliable selective estrogen receptor modulation under medical supervision for long-term treatment plans and improved patient outcomes.

Manufactured under stringent quality control standards, these pharmaceutical-grade tablets ensure precise 20mg dosage consistency and meet IP specifications. They are trusted by hospital formularies, pharmacy networks, and healthcare distribution channels for their reliable performance in clinical settings where treatment adherence and therapeutic efficacy are critical to patient care.
- Adjuvant therapy for early-stage breast cancer patients following primary treatment
- Reduction of cancer incidence in women with high-risk factors or genetic predisposition
- Treatment of metastatic breast cancer in estrogen receptor-positive cases
- Management of gynecomastia in men undergoing specific hormone therapies
- Specialized applications in fertility treatments under medical supervision

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

Biogenix Pharma UK Limited, Maharashtra
Verified
IndiaMaharashtra, India
Manufacturer
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Pharmaceutical Tamoxifen Citrate Tablets IP 20mg

Pharmaceutical Tamoxifen Citrate Tablets IP 20mg deliver reliable selective estrogen receptor modulation for hormone-positive breast cancer treatment, manufactured with high-quality materials and strict compliance for consistent therapeutic results.

Min. Order Quantity: 1 units

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Biogenix Pharma UK Limited
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier

Related Products